RIZZA, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 3.627
AS - Asia 2.818
EU - Europa 1.974
SA - Sud America 878
AF - Africa 157
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.462
Nazione #
US - Stati Uniti d'America 3.463
SG - Singapore 1.036
BR - Brasile 649
CN - Cina 601
UA - Ucraina 555
VN - Vietnam 519
DE - Germania 446
IT - Italia 221
AT - Austria 182
FR - Francia 159
SE - Svezia 146
IN - India 101
CA - Canada 94
BD - Bangladesh 90
TR - Turchia 85
AR - Argentina 71
KR - Corea 69
FI - Finlandia 63
IQ - Iraq 48
HK - Hong Kong 45
GB - Regno Unito 44
SN - Senegal 43
ZA - Sudafrica 36
CO - Colombia 34
EC - Ecuador 34
ID - Indonesia 33
MX - Messico 32
RU - Federazione Russa 30
PY - Paraguay 24
VE - Venezuela 24
PK - Pakistan 23
PL - Polonia 19
MA - Marocco 18
NL - Olanda 17
PE - Perù 16
SA - Arabia Saudita 16
BE - Belgio 15
PH - Filippine 15
CL - Cile 14
DZ - Algeria 13
MY - Malesia 13
AZ - Azerbaigian 12
ES - Italia 12
AE - Emirati Arabi Uniti 11
JO - Giordania 11
TN - Tunisia 11
LT - Lituania 10
OM - Oman 10
UZ - Uzbekistan 10
EG - Egitto 9
KZ - Kazakistan 9
PA - Panama 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
JP - Giappone 8
KE - Kenya 8
CZ - Repubblica Ceca 7
IR - Iran 7
JM - Giamaica 7
NG - Nigeria 7
IE - Irlanda 6
LB - Libano 6
PS - Palestinian Territory 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
CR - Costa Rica 5
HN - Honduras 5
KG - Kirghizistan 5
NP - Nepal 5
ET - Etiopia 4
IL - Israele 4
RO - Romania 4
UY - Uruguay 4
AO - Angola 3
BH - Bahrain 3
GE - Georgia 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
ME - Montenegro 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
BB - Barbados 1
BT - Bhutan 1
CY - Cipro 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
Totale 9.451
Città #
Singapore 362
Chandler 357
Jacksonville 338
San Jose 294
Dallas 272
San Mateo 220
Ho Chi Minh City 212
Dearborn 186
Ashburn 184
Boardman 181
Beijing 166
New York 139
Vienna 122
Council Bluffs 115
Hanoi 104
Lauterbourg 72
Seoul 69
Shanghai 68
Izmir 67
Lawrence 63
Roxbury 63
São Paulo 59
Grafing 57
Ottawa 54
Munich 52
Rende 46
Des Moines 45
Helsinki 44
Hong Kong 44
Dakar 43
Los Angeles 43
Hefei 37
Bremen 36
Inglewood 35
Haiphong 31
Ann Arbor 29
Wilmington 29
Brooklyn 28
Santa Clara 26
Cambridge 23
Da Nang 23
Guangzhou 23
Toronto 19
Turku 19
Columbus 18
Rio de Janeiro 18
Baghdad 17
Johannesburg 17
Orem 16
Pune 16
Brussels 15
Seattle 15
Cape Town 14
San Francisco 14
Warsaw 14
Düsseldorf 13
Hanover 13
Ogden 13
The Dalles 13
Baku 12
Curitiba 12
Dhaka 12
Quito 12
Asunción 11
Belo Horizonte 11
Cosenza 11
Florence 11
Lima 11
Milan 11
Redwood City 11
Amman 10
Falls Church 10
London 10
Tashkent 10
Amsterdam 9
Biên Hòa 9
Campinas 9
Caracas 9
Catanzaro 9
Guayaquil 9
Hải Dương 9
Montreal 9
Nanjing 9
Tianjin 9
Atlanta 8
Buenos Aires 8
Chennai 8
Frankfurt am Main 8
Goiânia 8
Houston 8
Lahore 8
Medellín 8
Phoenix 8
Porto Alegre 8
Wuhan 8
Augusta 7
Boston 7
Brasília 7
Chicago 7
Guarulhos 7
Totale 5.103
Nome #
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression 250
17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells 239
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 222
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression 210
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression. 208
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination 202
" L'attività antiproliferativa dell'oleuropeina e dell'idrossitirisolo nelle cellule di carcinoma mammario MCF-7 è associata all'inibizione delle MAP chinasi." 198
Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma 194
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 193
A new role of leptin as amplifier of estrogen signaling in breast cancer. 187
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 185
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells 183
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor 182
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ER. 2nd Joint Meeting of Pathology and Laboratory Diagnostics, 2014 September 17-20, Palermo, Italy. Am J Pathol ,184(Suppl):S34 Abstract MTP1, 2014. Oral communication 177
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 167
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter 164
Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells 160
FoxO3a mediates the inhibitory effects of the antiepileptic drug Lamotrigine on breast cancer growth 159
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ERα 158
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 157
Evidences that Estrogen Receptor alpha interferes with adiponectin effects on breast cancer cell growth 156
Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells 154
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 150
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 148
Effetti del TGF-β e del Bergaptene in line cellular di tumore mammario umano ERα(+) ed ERα(-) 140
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation 136
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity 135
Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis 135
Mammary Epithelium-Specific Conditional Expression of Human Mutant Ki-Ras in Mice Generates Estrogen Receptor Alpha (ER)-Positive Mammary Adenocarcinomas 132
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 130
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 129
Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line 128
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 127
Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1 118
Evidence that estradiol, through a short non genomic loop, downregulates PTB1B and enhances aromatase activity in MCF7 cells 108
In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer. 108
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 107
Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production 105
Rapid estradiol/ER{alpha} signaling enhances aromatase enzymatic activity in breast cancer cells 104
Evidence that estradiol through non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 104
Effetti modulatori dell’estradiolo prodotto in situ sull’espressione di Fas Ligand in una linea cellulare sertoliana:TM4 104
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-β estradiol and aromatase activity in MCF-7 cells. 104
Estrogen Receptor-β, through Sp1, Recruits a Corepressor Complex to the Estrogen Receptor-α Gene Promoter in Breast Cancer Cells 104
Effetto up-regolatorio dell’estradiolo prodotto in situ sull’espressione di FAS-ligand nella linea cellulare sertoliana TM4 103
“Inhibitory role of Farnesoid X Receptor ligands aromatase expression in Leydig tumor cells” 103
Production of Plant-Derived Oleuropein Aglycone by a Combined Membrane Process and Evaluation of Its Breast Anticancer Properties 103
Evidence that farnesoid X receptor ligand through SF-1 responsive element inhibits aromatase expression in Leydig tumor cells 102
The antiepileptic drug Lamotrigine, through FoxO3a, inhibits breast cancer growth and development both in vitro and in vivo. Pellegrino M, Rizza P, Giordano F, Spina E, Ceraldi R, Andò S, Morelli C, Sisci D. 102
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-beta estradiol and aromatase activity in MCF-7 cells 101
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 98
Inhibitory role of Farnesoid X Receptor ligands on aromatase expression in Leydig tumor cells. 96
OHPg/PR-B Through Beclin1 Mediate Autophagy In Breast Cancer Cells 95
Evidence that PI3K/Akt pathway is involved in the short non genomic autocrine loop between 17beta-estradiol and aromatase activity in breast cancer 92
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 92
Nuclear compartimentalization of protein involved in cell survival is induced by low doses of paclitaxel: an early event which precedes block of MCF-7 cell cycle progression 92
PPARγ ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 87
Leptin induces functional activation of ERalpha and enhances aromatase expression in breast cancer cells 87
PPAR-gamma ligand rosiglitazone counteracts the stimulatory effect of leptin on breast cancer growth 86
Evidence that leptin induces HER2 expression and enhances the stem cell population in breast cancer 85
Evidences that Leptin Induces HER2 Expression and Enhances Stem Cells Population in Breast Cancer. 84
PPARγ ligand rosiglitazone counteracts the stimulatory effectsof leptin on breast cancer growth 83
Leptin induces functional activity of ERalpha and stimulates aromatase expression in breast cancer cells: a new potential role on tumor progression 82
Farnesoid X receptor ligand down-regulates aromatase expression in Leydig tumor cells 79
PPARgamma ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 77
Leptin induces functional activation of ERα and enhances aromatase expression in breast cancer cells 75
Leptin stimulates aromatase expression and induces functional activaty of ERalpha in breast cancer cells: a new potential role on tumor progression. 74
Leptin induces HER2 expression and enhances stem cells population in breast cancer. 73
First evidence of non-genomic estradiol induced up-regulation of aromatase enzymatic activity in MCF-7 breast cancer cells 73
PPAR gama ligand rosiglitazone counteracts the stimmulatory effect of leptin on breast cancer growth 67
Leptin stimulates, via MAPKinase, aromatase P II/1.3 promoter activity in MCF-7 cell line 64
The pMAPK/pAMPK ratio modulates the effect of adiponectin on breast cancer cell growth 63
Evidence that estradiol, through a short non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 62
Leptin stimulates aromatase expression and induces functional activity of ERα in breast cancer cells: a new potential role on tumor progression 57
Fas Ligand expression in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction via SP-1 57
Leptin stimulates, via MAPKinase, aromatase PII/I.3 promoter activity in MCF-7 cell line 46
null 40
null 34
Fas ligand expression in TM4 cells is up-regulated by estrdiol through Estrogen Receptor α interaction with Sp-1 32
null 31
null 30
null 29
null 29
null 28
null 27
Totale 9.581
Categoria #
all - tutte 49.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 0 0 0 0 0 64
2021/2022952 14 123 0 49 109 69 9 241 11 5 124 198
2022/2023922 135 110 45 99 128 73 24 94 101 19 70 24
2023/2024585 65 18 31 12 17 173 16 35 42 22 33 121
2024/20251.331 106 180 39 101 51 44 62 85 241 104 117 201
2025/20264.136 474 195 472 362 759 252 435 209 316 312 181 169
Totale 9.581